Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1370 results about "Guide RNA" patented technology

Guide RNAs (a.k.a. gRNA) are the RNAs that guide the insertion or deletion of uridine residues into mitochondrial mRNAs in kinetoplastid protists in a process known as RNA editing. The terms "guide RNA" and "gRNA" are also used in prokaryotic DNA editing involving CRISPR and Cas9.

Methods and compositions for editing nucleotide sequences

The present disclosure provides new prime editor guide RNAs for prime editing, constructs for prime editing, and methods for using same. In addition, the present disclosure provides compositions and methods for conducting prime editing of a target DNA molecule (e.g., a genome) that enables the incorporation of a nucleotide change and / or targeted mutagenesis (e.g., insertion or deletion). The nucleotide change can include a single-nucleotide change (e.g., any transition or any transversion), an insertion of one or more nucleotides, or a deletion of one or more nucleotides. More in particular, the disclosure provides fusion proteins comprising nucleic acid programmable DNA binding proteins (napDNAbp) and a polymerase (e.g., reverse transcriptase), which is guided to a specific DNA sequence by a prime editor RNA (PEgRNA). The prime editor guide RNA comprises an extension arm that provides a DNA synthesis template sequence which encodes a single strand DNA flap, which is homologous to an endogenous DNA sequence, but which contains the desired one or more nucleotide changes and which, following synthesis by the polymerase (e.g., reverse transcriptase), becomes incorporated into the target DNA molecule.
Owner:HOWARD HUGHES MEDICAL INST +2

Improved crispr / cas guide RNA (GRNA)

PCT designated stage expiredWO2024231575A1Special deliveryActivity regulationPharmaceutical drugGuide RNA
Modified guide RNAs for EV-mediated delivery of gene editing machinery, complexes, EVs, EV producer cells and pharmaceutical compositions comprising the same, and uses thereof, for example to treat genetic diseases and disorders.
Owner:EVOX THERAPEUTICS LTD

Compositions for treating cancer with KRAS mutations and uses thereof

The present application provides guide RNAs and genome-editing complexes or nanoparticles that are useful for specifically targeting a mutated KRAS. Exemplary genome-editing complexes or nanoparticles comprise cell-penetrating peptides, and optionally a DNA nuclease (such as Cas9) or a polynucleotide encoding the DNA nuclease.
Owner:AADIGEN LLC

Method for detecting infectious salmon anemia virus in salmon based on RAA-CRISPRCas12a and application

The invention relates to the technical field of virus detection, and discloses a method for detecting infectious salmon anemia virus in salmon based on RAA-CRISPRCas12a and application, and the method comprises the following steps: dispersing a Cas12a protein solution, a guide RNA solution, an ssDNA reporter probe solution, a ribonuclease inhibitor, nuclease-free water and an RAA reactant in a buffer solution, incubating, and detecting the infectious salmon anemia virus in salmon based on RAA-CRISPRCas12a. Carrying out fluorescence intensity detection; the amino acid sequence of the Cas12a protein is as shown in SEQ ID NO. 6. The novel Cas12a protease with better cutting activity is used in the method, and can be successfully applied to detection of the infectious salmon anemia virus in salmons.
Owner:NANJING NORMAL UNIVERSITY

Method for detecting salmon alphavirus in salmon based on RAA-CRISPRCas12a and application

The invention relates to the technical field of virus detection, and discloses a method for detecting salmon alphavirus in salmon based on RAA-CRISPRCas12a and application, the method comprises the following steps: dispersing a Cas12 protein solution, a guide RNA solution, an ssDNA reporter probe solution, a ribonuclease inhibitor, nuclease-free water and an RAA reactant in a buffer solution, incubating, and carrying out fluorescence intensity detection; the amino acid sequence of the Cas12 protein is as shown in SEQ ID NO. 5. The novel Cas12a protease with better cutting activity is used in the method, and can be successfully applied to detection of salmon alphavirus in salmons.
Owner:NANJING NORMAL UNIVERSITY

Methods and compositions for prime editing RNA

The present disclosure provides compositions and methods for the targeted modification of RNA molecules by RNA prime editing. The compositions and methods may be conducted invitro or in vivo within cells (e.g., human cells) for the therapeutic correction of disease-causing mutations and / or installation of motifs or mutations in RNA molecules of interest as a tool for scientific research. The disclosure provides compositions and methods for conducting RNA prime editing of a target RNA molecule (e.g., an RNA transcript) that enables the incorporation of one or more nucleotide changes and / or targeted mutagenesis of a target RNA molecule. The nucleotide change can include a single-nucleotide change, an insertion of one or more nucleotides, or a deletion of one or more nucleotides. More in particular, the disclosure provides a variety of configurations of the RNA prime editors each comprising a nucleic acid programmable RNA binding proteins (napRNAbp), such as Cas13, and an RNA-dependent RNA polymerase (RDRP), which are provided as fusion proteins or which can be separately provided in trans. The RNA prime editors are guided to a target RNA site by a guide RNA, which can be a rpegRNA that includes a template region for the synthesis of an RNA sequence to be installed on the RNA molecule attached to an available 3′ terminus. In others embodiments, the RNA template can be provided in trans.
Owner:THE BROAD INST INC +1

Methods and compositions for genomic integration

PCT designated stage expiredWO2025128722A2HydrolasesGenetic material ingredientsTransgeneGenome
Methods and compositions for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed. Specifically, provided herein comprises compositions comprising an RNA molecule comprising a reverse complement sequence comprising an exogenous sequence and homology arms, an RNA molecule comprising an endonuclease, and one or more guide RNAs for specific genomic integration of the exogenous sequence.
Owner:MYELOID THERAPEUTICS INC

Plant-derived Argonaute protein and application thereof

The invention discloses a plant-derived Argonaute protein and application thereof, and belongs to the technical field of gene editing and detection. The plant-derived Argonaute protein is specifically a protein with an amino acid sequence as shown in SEQ ID NO.1, or a protein which has at least 80% of homology with the amino acid sequence as shown in SEQ ID NO.1 and has corresponding functions; the Argonaute protein specifically cleaves target nucleic acid under mediation of guide nucleic acid, the guide nucleic acid is guide DNA or guide RNA, and the target nucleic acid is a DNA target or an RNA target. Compared with the reported eukaryotic Argonaute protein derived from unicellular organisms, the Argonaute protein used in the invention is derived from rice, has greater application potential in the field of animal and plant gene editing, not only has RNase activity and activity of cutting a DNA target by utilizing guide RNA, but also can cut the DNA target by utilizing guide DNA, so that the scheme of the invention has good application prospect.
Owner:HUBEI UNIV

Compositions for pcsk9 gene modification or editing and methods of use thereof

The invention provides a composition for modifying or editing a PCSK9 gene and a using method thereof, and particularly provides a composition for editing a PCSK9 gene target, the composition comprises a base editor for carrying out base editing on the PCSK9 gene target and guide RNA, the composition can effectively edit a target gene, and the composition has the advantages that the target gene can be effectively edited; the polypeptide can be used for treating diseases caused by abnormality of polynucleotide encoding the PCSK9 protein.
Owner:XINLITAI LIFE SCIENCES (SHENZHEN) CO LTD

Methods and compositions for prime editing nucleotide sequences

Compositions and methods are provided herein for conducting prime editing of a target DNA molecule (e.g., a genome) that enables the incorporation of a nucleotide change and / or targeted mutagenesis. The compositions include fusion proteins comprising nucleic acid programmable DNA binding proteins (napDNAbp) and a polymerase (e.g., reverse transcriptase), which is guided to a specific DNA sequence by a modified guide RNA, named an PEgRNA. The PEgRNA has been altered (relative to a standard guide RNA) to comprise an extended portion that provides a DNA synthesis template sequence which encodes a single strand DNA flap which is synthesized by the polymerase of the fusion protein and which becomes incorporated into the target DNA molecule.
Owner:THE BROAD INST INC

CAS9 variants having non-canonical PAM specificities and uses thereof

The present disclosure provides Cas9 variants, and base editors comprising these variants, that recognize non-canonical protospacer adjacent motifs (PAMs) and have less restrictive PAM requirements for editing. The present disclosure provides Cas9 protein variants comprising one or more amino acid substitutions relative to wild-type Nme2Cas9. Fusion proteins comprising the Cas protein variants described herein are also provided by the present disclosure. Further provided herein are methods for editing a target nucleic acid using the Cas variants and fusion proteins provided herein. The present disclosure also provides guide RNAs, complexes, polynucleotides, cells, kits, and pharmaceutical compositions. Further described herein are phage-assisted continuous evolution (PACE) systems, vectors, methods, and devices.
Owner:THE BROAD INST INC +1

Methods and compositions for prime editing RNA

The present disclosure provides compositions and methods for the targeted modification of RNA molecules by RNA prime editing. The compositions and methods may be conducted invitro or in vivo within cells (e.g., human cells) for the therapeutic correction of disease-causing mutations and / or installation of motifs or mutations in RNA molecules of interest as a tool for scientific research. The disclosure provides compositions and methods for conducting RNA prime editing of a target RNA molecule (e.g., an RNA transcript) that enables the incorporation of one or more nucleotide changes and / or targeted mutagenesis of a target RNA molecule. The nucleotide change can include a single-nucleotide change, an insertion of one or more nucleotides, or a deletion of one or more nucleotides. More in particular, the disclosure provides a variety of configurations of the RNA prime editors each comprising a nucleic acid programmable RNA binding proteins (napRNAbp), such as Cas13, and an RNA-dependent RNA polymerase (RDRP), which are provided as fusion proteins or which can be separately provided in trans. The RNA prime editors are guided to a target RNA site by a guide RNA, which can be a rpegRNA that includes a template region for the synthesis of an RNA sequence to be installed on the RNA molecule attached to an available 3′ terminus. In others embodiments, the RNA template can be provided in trans.
Owner:THE BROAD INST INC +1

Novel method to modulate expression of an endogenous gene in a somatic cell

PCT designated stage expiredWO2025078824A1HydrolasesGenetically modified cellsIntracellularSomatic cell
The invention relates to a method of modulating the expression of an endogenous gene in a somatic cell derived from an induced pluripotent stem cell (iPSC), comprising differentiating an engineered iPSC capable of stable or inducible expression of a CRISPR-related protein into a somatic cell prior to introduction of a guide RNA (gRNA) sequence. The invention also relates to the engineered iPSC, cells obtained by the method and uses thereof.
Owner:BIO BIT LTD

Separated nuclease and application thereof

ActiveCN119053698AImprove gene editing efficiencySolve delivery difficultiesVectorsHydrolasesVector (molecular biology)Nuclease
The invention relates to the field of molecular biology, in particular to separated nuclease and application thereof. The invention also specifically relates to a nucleic acid for coding the nuclease and a nucleic acid construct, a guide RNA and a nucleic acid construct thereof, and a composition, a recombinant vector, a recombinant host cell and a kit containing the nuclease. The invention further particularly relates to a method for introducing double-strand breakage into the target gene of the host cell, a method for deleting, replacing or inserting the target gene of the host cell and a method for obtaining the host cell with the target gene deleted, replaced or inserted. The invention further specifically relates to application of the nuclease, nucleic acid and nucleic acid constructs encoding the nuclease, the guide RNA and nucleic acid constructs thereof, the composition, the recombinant vector or the recombinant host cell to introduction of double-strand breakage into a target gene of the host cell. The invention also relates to application in deletion, replacement or insertion of a target gene of a host cell and application in preparation of a medicine or a preparation.
Owner:BEIJING ASTRAGENOMICS TECHNOLOGY CO LTD

Method for regulating and controlling CRISPR-Cas protein activity through temperature and application thereof

The invention relates to the technical field of nucleic acid detection, in particular to a method for regulating and controlling CRISPR-Cas protein activity through temperature and application of the method, a CRISPR reaction system contains Cas protein, guide RNA, a nucleic acid reporter probe and a buffer solution, and then the cis-cleavage activity or trans-cleavage activity of the Cas protein is activated or inactivated by regulating and controlling the temperature of the reaction system; the guide RNA includes a guide RNA targeting a target nucleic acid sequence that does not contain a PAM site. Multiple detection can be realized only by using the same type of Cas protein, the design of PAM-free sgRNA or crRNA facilitates the selection of sgRNA or crRNA, meanwhile, the activity of PAM-free sgRNA or crRNA can be regulated and controlled by utilizing temperature rise, and the Cas protein with lower reaction temperature can be inactivated, so that the Cas protein cannot cause interference to the detection of the second stage.
Owner:WUXI TOLO PORT BIOMEDICAL TECH CO LTD

Dual nuclease systems for gene editing, methods of producing and using same

PCT designated stage expiredWO2025041085A1Organic active ingredientsNervous disorderEnzyme systemENCODE
Provided herein are dual cleaving chimeric nucleases comprising an I-TevI domain and a RNA-guided domain such as Cas9 for use in gene editing methods, as well as chimeric nuclease systems comprising a single nucleic acid that encodes said chimeric nuclease, one or more guide RNAs (gRNAs), one or more tRNAs, and optionally one or more donor polynucleotides. Also provided herein are methods of making and using such chimeric nucleases, chimeric nuclease systems, and nucleic acids encoding such chimeric nucleases and chimeric nuclease systems.
Owner:SPECIFIC BIOLOGICS INC

A programmable gene correction technology using CAS-polymerase constructs

In one aspect, the disclosure relates to a gene modification tool that fuses a Cas protein with a polymerase. This DSB-independent approach utilizes a DNA-RNA chimeric prime-editor-like guide RNAs (chimeric pegRNAs or cpegRNAs) to enable programmable DNA sequence replacement or excision at endogenous human genomic sites. The Cas9 and RNA portion of cpegRNA helps with targeting a gene, while the DNA portion of cpegRNA is used as a template by the polymerase to repair. Furthermore, the disclosed method can be used to introduce large DNA modifications in the genome.
Owner:UNIV OF FLORIDA RESEARCH FOUNDATION INC

Primer, kit and method for detecting crop root rot fusarium solani and application

The invention relates to the technical field of phytopathogen detection, and particularly discloses a primer, a kit and a method for detecting crop root rot fusarium solani and application, the primer comprises a specific RPA primer RPA-F and a specific RPA primer RPA-R; the specific RPA primer RPA-F is as shown in SEQ ID NO. 1, and the specific RPA primer RPA-R is as shown in SEQ ID NO. 2; the kit further comprises a guide RNA primer crRNA, and the guide RNA primer crRNA is as shown in SEQ ID NO. 3. The kit comprises a specific RPA primer RPA-F, a specific RPA primer RPA-R, a Cas12 protein, a T7 transcriptase, a crRNA DNA template, a DNA polymerase and a Cas12 / 13 nucleic acid detection test strip. The kit has the characteristics of good sensitivity, relatively good specificity and enough reliability.
Owner:ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES

Base editing system for optimizing engineered T cells and application thereof

The invention belongs to the field of gene engineering. Specifically, the invention relates to a base editing system for optimizing engineered T cells and application of the base editing system. The present invention provides a base editing system for modifying engineered T cells, comprising: i) a base editing polypeptide, and / or an expression construct encoding a base editing polypeptide, the base editing polypeptide comprising a DNA binding protein and at least one deaminase domain; ii) a guide RNA, and / or an expression construct encoding a guide RNA, the guide RNA targeting any one of TRAC, TGFBR2, PD-1, CISH, and / or FAS genomic regions, or any combination thereof. The base editing system disclosed by the invention has high efficiency of a gene editing tool and low Indel frequency, can realize accurate editing of T cell function enhancement related genes, and has important value for expanding application scenes of a base editing technology in the fields of preparation of safe and efficient engineered T cells and the like.
Owner:BEIJING QI BIODESIGN BIOTECHNOLOGY CO LTD

Application of CAS protein, method for detecting target nucleic acid molecule and kit

The present invention provides a use of a Cas protein, and a method and a kit for detecting target nucleic acid molecules. The method for detecting target nucleic acid molecules comprises adding a guide RNA, a Cas12a, and a nucleic acid probe into a reaction system containing target nucleic acid molecules to be detected, and detecting it after the reaction is completed.
Owner:SHANGHAI TOLO BIOTECH CO LTD

Methods and compositions for genomic integration

Methods and compositions for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed. Specifically, provided herein comprises compositions comprising an RNA molecule comprising a reverse complement sequence comprising an exogenous sequence and homology arms, an RNA molecule comprising an endonuclease, and one or more guide RNAs for specific genomic integration of the exogenous sequence.
Owner:MYELOID THERAPEUTICS INC

Adenine base editor for DFNB9 hearing loss repair

The invention discloses an adenine base editor for DFNB9 hearing loss repair, and belongs to the field of gene therapy of hearing repair. The fusion protein comprises nNme2Cas9, and adenine deaminase TadA-8e or TadA-8e-N108Q (adenine deaminase) or TadA-8e-N108Q-L145T (adenine deaminase). The invention further discloses a preparation method of the adenine deaminase. The amino acid sequences of the TadA-8e, the TadA-8e-N108Q and the TadA-8e-N108Q-L145T are respectively as shown in SEQ ID NO. 1 to SEQ ID NO. 3. The fusion protein and a guide RNA form a base editor. Compared with the prior art, the base editor is used as a treatment means, severe deafness can be recovered to a normal level, and the effect can be maintained for at least six months after treatment. In addition, the treatment window period is relatively long, and the method has clinical transformation significance.
Owner:SOUTHEAST UNIV

Compositions, systems, and methods for regulation of hepatitis b virus through targeted gene repression

Provided herein are epigenetic-modifying DNA-targeting systems, such as CRISPR-Cas / guide RNA (gRNA) systems, for the transcriptional repression of Hepatitis B viral (HBV) genes to promote a cellular phenotype that leads to the reduction of HBV infection. In some embodiments, the epigenetic-modifying DNA-targeting systems bind to or target a target site of at least one gene or regulatory element thereof in a Hepatitis B viral DNA sequence in cell. In some aspects, the provided systems relate to the transcriptional repression of one or more Hepatitis B viral gene and / or regulatory element thereof. In some aspects, also provided herein are methods and uses related to the provided compositions, for example in repressing Hepatitis B viral replication and expression in connection with Hepatitis B infections.
Owner:TUNE THERAPEUTICS INC

Antibody-mediated delivery of CAS9 to mammalian cells

In certain embodiments a construct for performing gene editing in a mammalian cell is provided. In certain embodiments the construct comprises a targeting moiety that binds a surface marker on a cell (e.g., surface receptor), where the targeting moiety is attached to a complex comprising a class 2 CRISPR / Cas endonuclease complexed with a corresponding CRISPR / Cas guide RNA that hybridizes to a target sequence within the genomic DNA of the cell.
Owner:RGT UNIV OF CALIFORNIA